SAFETY OF USTEKINUMAB IN OLDER IBD PATIENTS (≥60 YEARS): POOLED SAFETY ANALYSIS THROUGH 5 YEARS IN CD AND 2 YEARS IN UC AND ALL APPROVED INDICATIONS

Subrata Ghosh  1     Elyssa Ott  2     Christopher Gasink  2     Ye Miao  3     Colleen W. Marano  3     John Lynch  4     Maria T. Abreu     Aline Charabaty    
1 University of Birmingham,Birmingham,United Kingdom
2 Janssen Scientific Affairs, LLC,Horsham,United States
3 Janssen Research & Development, LLC,Spring House,United States
4 Janssen Research & Development, LL

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing